Terms used to describe functionalities in ocular genetics can produce more confusion than clarity. Such is the case with the term hypomorphic variant.
Read More
For patients with temporal lobe epilepsy, moderate or severe depression is associated with higher odds of having a worse cognitive phenotype.
Read More
Researchers observed a significant disconnect between self-reported PrEP adherence and laboratory markers of adherence among people who inject drugs.
Read More
Patients with psoriasis are known to be at a higher risk of various cardiovascular risk factors.
Read More
“Ultimately, these populations are quite diverse, so a solution that works for one safety-net hospital may not work for another,” says Shreya Patel, MD, MPH.
Read More
A curated eBook featuring 65th ASH Annual Meeting leukemia and lymphoma-focused studies, findings, and expert opinions.
Read More
Treating ctDNA-positive patients with stage II colon cancer adjuvant chemotherapy for 6 months did not lead to an improvement in ctDNA clearance.
Read More
A curated eBook featuring 2023 NACLC non-small cell lung cancer-focused studies, findings, and expert opinions.
Read More
Four-year follow-up data demonstrates the benefits of nivolumab plus chemotherapy over chemotherapy alone in newly diagnosed patients with advanced gastric cancer.
Read More
Phase 2 study shows postoperative radiotherapy improved recurrence-free survival in patients with hepatocellular carcinoma.
Read More
Diabetes can be a challenging condition to manage, even with perfect conditions, but this is even more true for those working with limited resources.
Read More
Glecirasib displayed promising anti-tumor activity in patients with KRAS G12C mutated pancreatic ductal adenocarcinoma (PDAC) previously treated with other therapies.
Read More
Women are significantly underrepresented in biotech leadership roles and confront the same gender gap within the larger healthcare umbrella.
Read More
Durvalumab + 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) resulted in a higher pathological complete response (pCR) rate than FLOT alone.
Read More
Study results indicate that switching from intravenous to subcutaneous vedolizumab in patients with IBD appears to be safe and effective.
Read More
The Tardive Dyskinesia Impact Scale complements the Abnormal Involuntary Movement Scale by combining clinician-rated and patient-reported perspectives.
Read More
Several studies were presented at the 2024 Crohn’s & Colitis Congress, covering the impacts on IBD of malnutrition, dietary supplements, and various diets.
Read More
Although many don’t think politics has a place in the exam room, political policies impact healthcare—leading some physicians to consider joining the fray.
Read More
Patient-reported outcomes on HRQOL in psoriasis are limited and require additional validation to properly assess individuals with the condition.
Read More
Research from ASH 2023 showed standard treatment options lack efficacy for patients who are positive for the TP53 mutation with AML.
Read More
